Skip Navigation

Research Opportunities

Faculty Mentor Research

The following provides a list of potential faculty members who may serve as research mentors to residents interested in pursuing research opportunities:

  • Gary J. Bassell, PhD: molecular mechanisms of disease, glutamate synapse function, neuronal localization of mRNA, mechanisms of fragile X syndrome
  • Greg S. Berns, MD, PhD: neuroimaging of human mental function, neurobiology of mental processing, mechanisms of appetitive and aversive emotional processing
  • Elisabeth B. Binder, MD, PhD: pathophysiology of affective disorders, genetic mechanisms of stress-response, gene x environment interactions in psychiatry, pharmacogenomic mechanisms
  • Bekh Bradley, PhD: pathophysiology of trauma-related disorders, pathophysiology of personality disorders, effects of developmental and adult trauma on psychopathology treatment of personality disorders and PTSD
  • J. Douglas Bremner, MD: neuroimaging – pet and fMRI, neural correlates of post-traumatic stress disorder and depression, pathophysiology of stress-related disorders, cognitive functioning in affective and anxiety disorders
  • Patricia Brennan, PhD: biopsychosocial mechanisms of risk of externalizing disorders in children and adolescents, prenatal risk factors in the development of psychopathology
  • Marianne Celano, PhDhealth services research, pediatric asthma, child maltreatment
  • Claire Coles, PhD: behavioral teratology of alcohol and drug exposures, novel intervention strategies for fetal alcohol syndrome
  • W. Edward Craighead, PhD: etiology and treatment of mood and anxiety disorders in adolescents, prevention of first episode of depression and other mood disorders
  • Joseph F. Cubells, MD, PhD: pathophysiology of psychiatric disorders, genetics of common psychiatric disorders, genetics of dopamine beta-hydroxylase pathway and noradrenergic function, gene x environment interactions
  • Brian Dias, PhD: impact of trauma on the nervous system, physiology, and reproductive biology of generations that have directly experienced trauma and their descendants 
  • Benjamin G. Druss, MD, MPH: pathophysiology and epidemiology of schizophrenia and severe mental illness, healthcare delivery and utilization, community psychiatry research, medicine-based evidence in mental health
  • Erica Duncan, MD: acoustic startle response, immune function in schizophrenia, cognitive remediation in schizophrenia, and metabolic effects of psychiatric medications
  • Boadie W. Dunlop, MD: pathophysiology and treatment of mood and anxiety disorders, novel pharmacological treatments for anxiety
  • Negar Fani, PhD: uses neuropsychological, affective neuroscience, fMRI and DTI methods to examine cognitive and emotional alterations in individuals with varying PTSD symptoms; aims to create a brain-behavior-based classification system to facilitate tailored treatments
  • Jennifer Felger, PhD: effects of inflammatory cytokines on neurotransmitters and neural circuits as they relate to behavioral change
  • Charles F. Gillespie (Rickey), MD, PhD: pathophysiology of stress related disorders, genetics of psychiatric disorders, interaction of medical and psychiatric disorders
  • Shannon L. Gourley, PhD: physiology of appetitive / addictive behavior, molecular approaches to prefrontal and orbitofrontal cortex function, molecular / cellular mechanisms of synaptic plasticity and drug addiction
  • Robert E. Gross, MD, PhD: restorative approaches (including cell and gene therapy) for neurodegenerative disorders, physiology of movement disorders (Parkinson's disease, tremor, dystonia), role of axon guidance molecules in the development and reconstruction of the nigrostriatal pathway
  • Ebrahim Haroon, MD: neural basis of behavioral change in medically healthy and medically ill patients, including patients with cancer
  • Adriana Hermida, MD: novel intervention approaches for treatment resistant depression including efficacy of ECT and associated changes in cognition and memory
  • Carol J. Hogue, PhD: maternal/health, healthcare delivery and utilization, community psychiatry research
  • Leonard Howell, PhD: non-human primate models of addiction, pathophysiology of substance addiction, neuroimaging with fMRI, neural correlates of substance addiction
  • Andrew Jenkins, PhD: molecular mechanisms of disease, GABAergic synapse function, GABA subunit regulation, mechanisms of anesthetic function
  • Tanja Jovanovic, PhD: physiological mechanisms of fear and anxiety in humans; interactions between PTSD, depression, and the HPA axis; maternal-child interactions and intergenerational transmission of trauma risk
  • Nadine J. Kaslow, PhD: pathophysiology of trauma-related disorders and depression; intimate partner violence and mental health symptoms, pathophysiology of suicidal behavior
  • Ami Klin, PhD: mechanisms of autism spectrum disorder, using visual scanning approaches in infants to detect biomarkers of autism spectrum disorders, attention regulation in autism spectrum disorders
  • James J. Lah, MD, PhD: pathophysiology of neurodegenerative diseases, mechanisms and treatment of Parkinson’s disease and Alzheimer’s disease
  • Allan I. Levey, MD, PhD: pathophysiology of neurodegenerative diseases, mechanisms and treatment of Parkinson’s disease and Alzheimer’s disease, molecular mechanisms of neurodegeneration
  • Helen S. Mayberg, MD: neuroimaging of emotional states, pathophysiology of affective disorders, deep-brain stimulation for treatment of depression, neural circuitry mediating depression and sadness
  • William McDonald, MD: pathophysiology and treatment of affective disorders, mechanism and efficacy of transcranial magnetic stimulation, treatment of geriatric depression, mechanisms and efficacy of ECT for depression
  • Vasiliki Michopoulos, PhD: how psychosocial stress exposure (including trauma) across the lifespan adversely affects behavior and physiology in a sex-specific manner, with the use of translational neuroscience approaches across non-humans and primates
  • Andrew H. Miller, MD: research interests in immunology, neuroendocrinology, behavioral medicine, psychiatric oncology and mood and anxiety disorders
  • Seth Norrholm, PhD: trauma-, stressor-, and anxiety-related disorders in combat and civilian populations
  • Michael J. Owens, PhD:molecular pharmacology of psychiatric disorders, animal models of psychiatric disorders, role of stress in mood, anxiety and psychotic disorders
  • Donald G. Rainnie, PhD: pathophysiology of stress-related affective disorders, electrophysiology of amygdala and emotional systems, mechanisms of serotonergic function
  • Mark H. Rapaport, MD:  pathophysiology of affective and psychotic disorders, brain-body interactions in mediating depression, complementary and alternative approaches to psychiatric disorders
  • Patricio Riva Posse, MD: treatment-resistant mood disorders, and the development of novel therapeutics for these disorders
  • Barbara O. Rothbaum, PhD: pathophysiology and treatment of anxiety disorders including PTSD, virtual reality exposure therapy
  • Mar M. Sanchez, PhD: pathophysiology of affective disorders, primate models of stress-related disorders, developmental risk factors for depression, hypothalamic-pituitary adrenal axis regulation
  • Jeff Sanders, MD, PhD: social impairments in psychopathologies like schizophrenia, including deficits in the ability to form affiliations, to regulate aggression in social contexts and to empathize with others
  • Alicia K. Smith, PhD:genetic and psychological risk for psychiatric disorders, gene x environment interactions, epigenetic approaches to psychiatric disorders
  • Michael Treadway, PhD: molecular and circuit-level mechanisms of psychiatric symptoms related to mood, anxiety, and decision-making
  • Elaine F. Walker, PhD: pathophysiology of schizophrenia, community psychiatry, epidemiology of severe mental illness
  • Stephen Warren, PhD: genetics of intellectual disability, including Fragile X syndrome, therapeutic approaches using mGluR antagonists for intellectual disability.  Discovery of gene variants influencing schizophrenia and/or psychosis susceptibility in 22q Deletion Syndrome by whole genome sequencing
  • David Weinshenker, PhD: physiology of noradrenergic nervous system, genetic molecular approaches of psychiatric disorders, animal models of mental illness
  • Zhexing Wen, PhD: use of cutting-edge technologies, including human non-integrated iPSCs and genome editing, to understand the core signature of psychiatric disorders and understand the biological functions of risk genes
  • Mark E. Wilson, PhD: physiology of sex-related endocrine system, pathophysiology of affective disorders, primate models of stress-related disorders, endocrine medication of mental illness
  • Larry J. Young, PhD: molecular and neural mechanisms of affiliation and pair bonding, molecular biology of the oxytocin and vasopressin systems physiology of sex-related endocrine system, animal models of mental illness
  • Stuart M. Zola, PhD: primate models of mental illness, neurobiology of learning and memory, physiology of hippocampus and mammalian memory systems